mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
Abstract Background Despite advancements in the successful use of immunotherapy in treating a variety of solid tumors, applications in treating brain tumors have lagged considerably. This is due, at least in part, to the lack of well-characterized antigens expressed within brain tumors that can medi...
Glavni autori: | , , , , , , , , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
BMC
2024-01-01
|
Serija: | Genome Medicine |
Teme: | |
Online pristup: | https://doi.org/10.1186/s13073-024-01281-z |